{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:22:00Z","timestamp":1791897720269,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People&apos;s Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.molmet.2023.101789","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T22:27:23Z","timestamp":1691533643000},"page":"101789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["PRDX1 Cys52Ser variant alleviates nonalcoholic steatohepatitis by reducing inflammation in mice"],"prefix":"10.1016","volume":"76","author":[{"given":"Zhonghao","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minglei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4317-7327","authenticated-orcid":false,"given":"Xiangyang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.molmet.2023.101789_bib1","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.molmet.2023.101789_bib2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrd.2015.3","article-title":"Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies","volume":"15","author":"Musso","year":"2016","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"10.1016\/j.molmet.2023.101789_bib3","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.molmet.2023.101789_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.molmet.2023.101789_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101122","article-title":"Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans","volume":"50","author":"Pafili","year":"2021","journal-title":"Mol Metab"},{"issue":"15","key":"10.1016\/j.molmet.2023.101789_bib6","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.1073\/pnas.91.15.7017","article-title":"Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes","volume":"91","author":"Chae","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.molmet.2023.101789_bib7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.tibs.2015.05.001","article-title":"Peroxiredoxins: guardians against oxidative stress and modulators of peroxide signaling","volume":"40","author":"Perkins","year":"2015","journal-title":"Trends Biochem Sci"},{"issue":"5619","key":"10.1016\/j.molmet.2023.101789_bib8","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1126\/science.1080405","article-title":"Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling","volume":"300","author":"Wood","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.molmet.2023.101789_bib9","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev-biochem-060815-014431","article-title":"Multiple functions and regulation of mammalian peroxiredoxins","volume":"86","author":"Rhee","year":"2017","journal-title":"Annu Rev Biochem"},{"issue":"44","key":"10.1016\/j.molmet.2023.101789_bib10","doi-asserted-by":"crossref","first-page":"27670","DOI":"10.1016\/S0021-9258(18)47038-X","article-title":"Thioredoxin-dependent peroxide reductase from yeast","volume":"269","author":"Chae","year":"1994","journal-title":"J\u00a0Biol Chem"},{"issue":"10","key":"10.1016\/j.molmet.2023.101789_bib11","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/emboj.2009.101","article-title":"Prdx1 inhibits tumorigenesis via regulating PTEN\/AKT activity","volume":"28","author":"Cao","year":"2009","journal-title":"EMBO J"},{"issue":"9\u201310","key":"10.1016\/j.molmet.2023.101789_bib12","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1101\/gad.313460.118","article-title":"PRDX1 and MTH1 cooperate to prevent ROS-mediated inhibition of telomerase","volume":"32","author":"Ahmed","year":"2018","journal-title":"Genes Dev"},{"issue":"6","key":"10.1016\/j.molmet.2023.101789_bib13","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/CIRCRESAHA.108.174870","article-title":"Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis","volume":"103","author":"Kisucka","year":"2008","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.molmet.2023.101789_bib14","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/hep.24104","article-title":"Concerted action of sulfiredoxin and peroxiredoxin I protects against alcohol-induced oxidative injury in mouse liver","volume":"53","author":"Bae","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.molmet.2023.101789_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.freeradbiomed.2019.04.012","article-title":"Circulating Peroxiredoxin-1 is a novel damage-associated molecular pattern and aggravates acute liver injury via promoting inflammation","volume":"137","author":"He","year":"2019","journal-title":"Free Radic Biol Med"},{"issue":"13","key":"10.1016\/j.molmet.2023.101789_bib16","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1016\/j.febslet.2005.04.028","article-title":"Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancer","volume":"579","author":"Chang","year":"2005","journal-title":"FEBS Lett"},{"issue":"6","key":"10.1016\/j.molmet.2023.101789_bib17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nm.2749","article-title":"Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain","volume":"18","author":"Shichita","year":"2012","journal-title":"Nat Med"},{"issue":"31","key":"10.1016\/j.molmet.2023.101789_bib18","doi-asserted-by":"crossref","first-page":"28775","DOI":"10.1074\/jbc.M505362200","article-title":"Oxidative stress-dependent structural and functional switching of a human 2-Cys peroxiredoxin isotype II that enhances HeLa cell resistance to H2O2-induced cell death","volume":"280","author":"Moon","year":"2005","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.molmet.2023.101789_bib19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2119\/molmed.2015.00033","article-title":"Cysteine oxidation targets peroxiredoxins 1 and 2 for exosomal release through a novel mechanism of redox-dependent secretion","volume":"21","author":"Mullen","year":"2015","journal-title":"Mol Med"},{"issue":"1","key":"10.1016\/j.molmet.2023.101789_bib20","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.1038\/s41467-022-34299-1","article-title":"Phosphorylation of 17beta-hydroxysteroid dehydrogenase 13 at serine 33 attenuates nonalcoholic fatty liver disease in mice","volume":"13","author":"Su","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.molmet.2023.101789_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/hep.32112","article-title":"Hepatocyte-specific deletion of adipose triglyceride lipase (adipose triglyceride lipase\/patatin-like phospholipase domain containing 2) ameliorates dietary induced steatohepatitis in mice","volume":"75","author":"Fuchs","year":"2022","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.molmet.2023.101789_bib22","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.cmet.2018.12.018","article-title":"Activation of anxiogenic circuits instigates resistance to diet-induced obesity via increased energy expenditure","volume":"29","author":"Xie","year":"2019","journal-title":"Cell Metab"},{"issue":"4","key":"10.1016\/j.molmet.2023.101789_bib23","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.cmet.2013.03.005","article-title":"Imbalance between neutrophil elastase and its inhibitor alpha1-antitrypsin in obesity alters insulin sensitivity, inflammation, and energy expenditure","volume":"17","author":"Mansuy-Aubert","year":"2013","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.molmet.2023.101789_bib24","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ab.2004.12.008","article-title":"Activity assay of mammalian 2-cys peroxiredoxins using yeast thioredoxin reductase system","volume":"338","author":"Kim","year":"2005","journal-title":"Anal Biochem"},{"issue":"3","key":"10.1016\/j.molmet.2023.101789_bib25","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.cmet.2011.06.015","article-title":"C2 domain-containing phosphoprotein CDP138 regulates GLUT4 insertion into the plasma membrane","volume":"14","author":"Xie","year":"2011","journal-title":"Cell Metab"},{"issue":"44","key":"10.1016\/j.molmet.2023.101789_bib26","doi-asserted-by":"crossref","first-page":"11989","DOI":"10.1039\/D0SC04888G","article-title":"Fluorescent probes for in\u00a0vitro and in\u00a0vivo quantification of hydrogen peroxide","volume":"11","author":"Ye","year":"2020","journal-title":"Chem Sci"},{"key":"10.1016\/j.molmet.2023.101789_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/0471140856.tx0710s49","article-title":"Measurement of peroxiredoxin activity","author":"Nelson","year":"2011","journal-title":"Curr Protoc Toxicol"},{"issue":"48","key":"10.1016\/j.molmet.2023.101789_bib28","doi-asserted-by":"crossref","first-page":"47361","DOI":"10.1074\/jbc.C300428200","article-title":"Reversible oxidation of the active site cysteine of peroxiredoxins to cysteine sulfinic acid. Immunoblot detection with antibodies specific for the hyperoxidized cysteine-containing sequence","volume":"278","author":"Woo","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.molmet.2023.101789_bib29","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jhep.2005.12.016","article-title":"Clinical characteristics and prognostic markers in disulfiram-induced liver injury","volume":"44","author":"Bjornsson","year":"2006","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.molmet.2023.101789_bib30","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-kappaB, inflammation, immunity and cancer: coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.molmet.2023.101789_bib31","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.cell.2018.09.053","article-title":"Obesity drives STAT-1-dependent NASH and STAT-3-dependent HCC","volume":"175","author":"Grohmann","year":"2018","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.molmet.2023.101789_bib32","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0901945","article-title":"Peroxiredoxin 1 stimulates secretion of proinflammatory cytokines by binding to TLR4","volume":"184","author":"Riddell","year":"2010","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.molmet.2023.101789_bib33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.str.2012.01.004","article-title":"Moonlighting by different stressors: crystal structure of the chaperone species of a 2-Cys peroxiredoxin","volume":"20","author":"Saccoccia","year":"2012","journal-title":"Structure"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877823001230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877823001230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:33:14Z","timestamp":1761957194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877823001230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":33,"alternative-id":["S2212877823001230"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2023.101789","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PRDX1 Cys52Ser variant alleviates nonalcoholic steatohepatitis by reducing inflammation in mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2023.101789","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101789"}}